Which of the following describes a commonly used harm reduction strategy in SUD care?

• A. Naloxone distribution and overdose prevention; syringe service programs; safer-use education; vaccination and counseling.
• B. Total abstinence for all patients.
• C. Punitive enforcement.
• D. Ignore overdose risk.

Answer: (A)

Harm reduction in substance use disorder care focuses on reducing the negative health consequences of use and meeting people where they are, rather than insisting on immediate abstinence. The described strategies—distributing naloxone and promoting overdose prevention; syringe service programs to prevent infections; safer-use education to minimize harm from use; and vaccination plus counseling to connect individuals with healthcare—embody this approach. Naloxone distribution saves lives by reversing overdoses in the moment and empowering communities to act quickly. Syringe service programs reduce the spread of HIV and hepatitis C and often serve as a bridge to additional care. Safer-use education helps people minimize injuries and risks associated with use, while vaccination and counseling improve overall health and link individuals to longer-term treatment, when they’re ready. Together, these components address real-world needs, reduce mortality and disease transmission, and build trust with people who use substances, making it more likely they’ll seek further help when they choose. In contrast, total abstinence for all patients, punitive enforcement, and ignoring overdose risk do not align with harm reduction principles, as they can increase harm, stigma, and barriers to care.